Related Experiment Video
Updated: Jul 28, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Medication Overuse Headache: an Updated Review and Clinical Recommendations on Management
Megan A Hird1, Claire H Sandoe2,3
1Division of Neurology, Department of Medicine, University of Toronto, Toronto, Canada.
Overview:
Medication overuse headache (MOH) is highly prevalent among individuals with primary headache disorders.
Purpose Of Review:
(1) Provide an update on epidemiology, risk factors, and treatment strategies of MOH and (2) provide recommendations on the management of MOH.
Recent Findings:
The prevalence of MOH ranges from 0.5 to 7.2%. Risk factors for MOH include female sex, lower socioeconomic status, some psychiatric conditions, and substance use disorders, among others. Recent large clinical trials support preventative therapy as an integral component of MOH management. Emerging clinical trial evidence supports anti-CGRP mAbs as effective preventative treatments among individuals with migraine and MOH. Among the large clinical trials, candesartan, topiramate, amitriptyline, and onabotulinumtoxinA were the most used preventative therapies, providing further support for these agents. MOH management requires a multifaceted and patient-centered approach that involves patient education, behavioral interventions, withdrawal of the overused medication, and initiation of preventative medication.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Classes and Categories
Rheumatic Heart Disease III: Medical Management
Analgesia and Pain Management
Desensitization and Tachyphylaxis

